Published in J Pept Sci on November 01, 1999
Ultrafast spectroscopy reveals subnanosecond peptide conformational dynamics and validates molecular dynamics simulation. Proc Natl Acad Sci U S A (2002) 1.34
Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes. Angew Chem Int Ed Engl (2015) 1.17
Ultrafast conformational dynamics in cyclic azobenzene peptides of increased flexibility. Biophys J (2004) 0.87
A conformational two-state peptide model system containing an ultrafast but soft light switch. Biophys J (2005) 0.78
Photoswitchable precision glycooligomers and their lectin binding. Beilstein J Org Chem (2014) 0.75
Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell (2000) 7.25
A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42
Mutational studies on HslU and its docking mode with HslV. Proc Natl Acad Sci U S A (2000) 1.79
The structure of a model pulmonary surfactant as revealed by scanning force microscopy. Biophys J (1997) 1.68
[Di-tert.-butyl-dicarbonate, a useful tert.-Butyloxycardonylating reagent (author's transl)]. Hoppe Seylers Z Physiol Chem (1976) 1.48
Comparison of standard endoscopic submucosal dissection (ESD) versus an optimized ESD technique for the colon: an animal study. Endoscopy (2009) 1.44
The substrate translocation channel of the proteasome. Biochimie (2001) 1.29
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia (2010) 1.11
Partial retro-inverso analogues of somatostatin: pairwise modifications at residues 7 and 8 and at residues 8 and 9. Biochemistry (1985) 1.08
Developing clinical teachers and their organizations for the future of medical education. Med Educ (2001) 1.07
Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes. J Biol Chem (2001) 1.06
Atomic mutations at the single tryptophan residue of human recombinant annexin V: effects on structure, stability, and activity. Biochemistry (1999) 1.05
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases. FEBS Lett (1996) 1.04
Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998-2000. Am J Epidemiol (2005) 1.02
Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J Biol Chem (1998) 1.00
Synthesis and conformational analysis of apamin analogues with natural and non-natural cystine/selenocystine connectivities. Biopolymers (2000) 1.00
Unusual properties of the fungal conventional kinesin neck domain from Neurospora crassa. EMBO J (2001) 1.00
Photomodulation of conformational states. I. Mono- and bicyclic peptides with (4-amino)phenylazobenzoic acid as backbone constituent. Biopolymers (2000) 1.00
Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats. Brain Res (1976) 0.98
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes. Chem Biol (1999) 0.97
Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds. J Pept Sci (1998) 0.97
Fast intracellular pH determination in single cells by flow-cytometry. Naturwissenschaften (1981) 0.96
Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci U S A (1999) 0.96
Synthesis of beta-(1-azulenyl)-L-alanine as a potential blue-colored fluorescent tryptophan analog and its use in peptide synthesis. J Pept Sci (2000) 0.95
A case-control study of self-reported exposures to pesticides and pancreas cancer in southeastern Michigan. Int J Cancer (1997) 0.95
Intervesicle cross-linking with integrin alpha IIb beta 3 and cyclic-RGD-lipopeptide. A model of cell-adhesion processes. Biochemistry (2000) 0.94
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci (1999) 0.94
Atomic mutations in annexin V--thermodynamic studies of isomorphous protein variants. Eur J Biochem (1998) 0.94
Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. Biochemistry (1993) 0.93
Bioincorporation of telluromethionine into proteins: a promising new approach for X-ray structure analysis of proteins. J Mol Biol (1997) 0.93
The influence of secretin, glucagon and other peptides, of amino acids, prostaglandin endoperoxide analogues and diazepam on the level of adenosine 3',5'-cyclic monophosphate in neuroblastoma x glioma hybrid cells. J Neurochem (1979) 0.93
Preferences for shared decision making in chronic pain patients compared with patients during a premedication visit. Acta Anaesthesiol Scand (2006) 0.93
Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J Biol Chem (1999) 0.92
Studies on polypeptides. XLV. Structure-function studies in the beta-corticotropin series. J Med Chem (1970) 0.92
Plasma levels of opioid peptides after sunbed exposures. Br J Dermatol (2002) 0.92
Relation between structure and function in some partially synthetic ribonucleases S'. I. Kinetic determinations. Biochim Biophys Acta (1972) 0.92
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J Biol Chem (2000) 0.92
Activation of snake venom metalloproteinases by a cysteine switch-like mechanism. FEBS Lett (1993) 0.91
Synthesis of peptide analogs of the N-terminal eicosapeptide sequence of ribonuclease A. VII. Synthesis of ile, orn -and ala, orn -eicosapeptides. J Am Chem Soc (1967) 0.89
Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem (1997) 0.89
Photomodulation of conformational states. II. Mono- and bicyclic peptides with (4-aminomethyl)phenylazobenzoic acid as backbone constituent. Biopolymers (2000) 0.89
The disulfide-coupled folding pathway of apamin as derived from diselenide-quenched analogs and intermediates. Protein Sci (1999) 0.89
Heterotrimeric collagen peptides as fluorogenic collagenase substrates: synthesis, conformational properties, and enzymatic digestion. Biochemistry (2000) 0.89
Toward a high-resolution structure of phospholamban: design of soluble transmembrane domain mutants. Biochemistry (2000) 0.88
Oxidative folding of cystine-rich peptides vs regioselective cysteine pairing strategies. Biopolymers (1996) 0.88
1-(tert-butylthio)-1,2-hydrazinedicarboxylic acid derivatives. New reagents for the introduction of the S-tert-butylthio group into cysteine and cysteine derivatives. Hoppe Seylers Z Physiol Chem (1982) 0.88
The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope. J Immunol (1995) 0.88
Molecular structure of the cyanobacterial tumor-promoting microcystins. FEBS Lett (1994) 0.87
Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth (2000) 0.87
Ultrafast conformational dynamics in cyclic azobenzene peptides of increased flexibility. Biophys J (2004) 0.87
Painful dysaesthesias following peripheral nerve injury: a clinical and electrophysiological study. Brain Res (1989) 0.87
Isomorphous replacement of cystine with selenocystine in endothelin: oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]-endothelin-1. J Mol Biol (1998) 0.87
Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev (1996) 0.87
Anthrax in animals and a farmer in Alto Adige, Italy. Euro Surveill (2006) 0.86
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase. Proc Natl Acad Sci U S A (2000) 0.85
Review of 1600 water births. Does water birth increase the risk of neonatal infection? J Matern Fetal Neonatal Med (2005) 0.85
Endotoxemia in organ donors: graft function following liver transplantation. Transpl Int (2000) 0.85
Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V. Proc Natl Acad Sci U S A (1998) 0.85
A new surgical model for hepatectomy in pigs. Eur Surg Res (2007) 0.84
Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci (1999) 0.84
Chalcogen-analogs of amino acids. Their use in X-ray crystallographic and folding studies of peptides and proteins. Biol Chem (1997) 0.84
Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. FEBS Lett (1983) 0.84
Proteins with beta-(thienopyrrolyl)alanines as alternative chromophores and pharmaceutically active amino acids. Protein Sci (2001) 0.84
Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. J Biol Chem (1999) 0.83
Conformational analysis of a IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulations. Biopolymers (1991) 0.83
Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro. Regul Pept (1982) 0.83
Analytical solution to the Lipari-Szabo model based on the reduced spectral density approximation offers a novel protocol for extracting motional parameters. J Magn Reson (2001) 0.83
New synthesis of somatostatin according to the S-tert-butylthiocysteine procedure. Biopolymers (1981) 0.83
Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments. J Mol Biol (1999) 0.82
Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. FEBS Lett (1998) 0.82
Incorporation of beta-selenolo[3,2-b]pyrrolyl-alanine into proteins for phase determination in protein X-ray crystallography. J Mol Biol (2001) 0.82
A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure. Eur J Biochem (1989) 0.82
Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs. Regul Pept (1984) 0.82
Folding motifs induced and stabilized by distinct cystine frameworks. Protein Eng (1998) 0.82
Relation between structure and function in some partially synthetic ribonucleases S'. Enzymic and spectroscopic investigation on [Orn10, Asn14]-RNase S' and 1epsilon, 7epsilon, 10delta-triguanidino-[Orn10, Asn14]-RNase S'. Eur J Biochem (1975) 0.82
A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope. J Immunol (1996) 0.81
Infrastructure and clinical practice for the detection and management of trauma-associated haemorrhage and coagulopathy. Eur J Trauma Emerg Surg (2014) 0.81
Bivalent inhibition of human beta-tryptase. Chem Biol (2001) 0.81
The uPA/uPA receptor system as a target for tumor therapy. Drug News Perspect (2001) 0.81
Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Peptides (1986) 0.81
Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. Epilepsia (1999) 0.81
Epoxysuccinyl peptide-derived affinity labels for cathepsin B. FEBS Lett (2000) 0.81
Partial trisomy 11q in a female infant with Robin sequence and congenital heart disease. Cleft Palate Craniofac J (1992) 0.81
Enkephalin evokes biochemical correlates of opiate tolerance and dependence in neuroblastoma x glioma hybrid cells. FEBS Lett (1976) 0.81
Cyclodextrins as templates for the presentation of protease inhibitors. FEBS Lett (1996) 0.81
[Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide]. Hoppe Seylers Z Physiol Chem (1981) 0.81
[Use of peridural catheters in the treatment of postoperative pain after spinal instrumentated fusion--an experience report]. Z Orthop Ihre Grenzgeb (2002) 0.81
Synthesis of bivalent inhibitors of eucaryotic proteasomes. J Pept Sci (2000) 0.81
Effect of Nin-formylation of the tryptophan residue on gastrin (HG-13) binding and on gastric acid secretion. Eur J Pharmacol (1982) 0.80
Bimodal regulation of pancreatic exocrine function in vitro by somatostatin-28. Am J Physiol (1983) 0.80
Peptides related to beta-lipotropin with opioid activity. Effects on levels of adenosine 3':5'-cyclic monophosphate in neuroblastoma x glioma hybrid cells. FEBS Lett (1977) 0.80